News
Menstruation costs £20,359 a lifetime, sparking calls for Government action

A new report by Clue has revealed the ‘Cost of Bleeding’ – a deep dive into the true cost of menstruation and the impact of related expenses adding up year after year.
The consumer research reveals that, on average, respondents spend an estimated £41 on their cycle each month, amounting to an astounding £20,359 across a 38-year menstrual lifetime.
On the back of the report, Clue has joined forces with media personality and women’s health advocate Ashley James to raise awareness of the Cost of Bleeding as part of its commitment to health equity.
Together, they are petitioning the Government to make period products free in England.
James said: “It is shocking that in this day and age that the simple biological reality of having a period comes with such a heavy price tag.
“Clue’s ‘Cost of Bleeding’ research shows that this isn’t just about the price of a box of tampons; it’s about recognising and understanding the hidden costs in stained clothes, pain management and the mental toll of managing these costs every single month.
“I’m proud to partner with Clue in campaigning for free access to period products in England – this shouldn’t be a luxury, it’s essential.”
Period products alone account for an average of £18 per month, the report found, but the total figure extends far beyond the essentials, revealing hidden costs incurred for pain relief, cleaning, clothing and even depleted productivity.
£142 per year is spent on symptom relief including painkillers, supplements and hot water bottles – adding £5,389 across a lifetime – while 27 per cent of respondents pay for private healthcare to manage conditions such as PCOS or endometriosis.
37 per cent of respondents have struggled to afford period products, with two in five (39 per cent) cutting back on essentials like food, bills or transport to pay for them.
What’s more, nearly 40 per cent have used “non-period” alternatives such as tissues or wipes in place of pads due to the cost.
Additionally, an average of £126 per year is spent replacing stained clothing, with 56 per cent also replacing bedding – adding £1,295 across a lifetime.
Furthermore, 79 per cent of respondents spend on emergency or ‘just in case’ supplies, including overpriced convenience items or emergency taxis after leaks.
The ‘Cost of Bleeding’ extends beyond personal finances, too.
44 per cent of those in employment said it “got in the way of doing their job”, while a further 41 per cent have missed a partial or full day of work in the last year due to menstrual symptoms.
Some experience a toll on mental health and wellbeing, with more than a third (36 per cent) agreeing the cost of managing their period is a direct source of stress and anxiety.
The anxiety is compounded by the economic climate; three quarters (75 per cent) of respondents feel the financial burden of women’s health needs has increased significantly in the last five years.
Amid the ongoing cost-of-living crisis, 82 per cent want period products to be free and more widely accessible in UK schools, universities and workplaces, while 67 per cent believe the cost of menstruation is not discussed enough.
Rhiannon White, CEO at Clue said: “Clue exists to help people understand and advocate for their bodies. Addressing the ‘Cost of Bleeding’ is a critical step in our mission to close the women’s health gap and ensure equity for women and people with cycles.
“We have always used our platform, and responsibility as a brand, to advocate for systemic change, and will continue to use our voice to speak out on behalf of issues that women face today, in a bid to fulfil our mission – of enabling a world where women live better.
“We encourage all men, women and people with cycles to sign the petition.”
As well as campaigning for long-term action, Clue is taking immediate steps by offering free Clue Plus subscriptions to all petition signatories.
Clue Plus provides access to evidence-based health insights, enhanced features, advanced analysis, and additional content and modes. Clue Plus subscribers also get exclusive discounts via a number of Clue’s period care partners.
Sign the petition at Change.org, and visit helloclue.com to unlock your free Clue Plus subscription (valid for 12 months).
Wellness
Gut-friendly foods may damage heart, charity warns
News
Diabetes patients face increased risk of undiagnosed heart failure

People with diabetes may have undiagnosed heart failure that could be detected by a simple screening blood test, research suggests.
The TARTAN-HF trial found that one in four patients with diabetes who had at least one other risk factor for heart failure had undiagnosed heart failure detected through screening with a blood test and ultrasound scanning of the heart.
Experts said the findings show the extent of unrecognised heart failure in people with diabetes, and how the condition can be detected using a widely available blood test called NT-proBNP, which measures how much strain the heart is under.
They suggest a heart failure screening programme for diabetics could improve diagnosis rates, lead to earlier treatment and potentially reduce the risk of hospitalisation and death.
The study, involving 700 patients, was led by the University of Glasgow in collaboration with AstraZeneca, Roche Diagnostics, Us2.ai, NHS Greater Glasgow and Clyde and NHS Lanarkshire.
Dr Kieran Docherty, clinical senior lecturer at the University of Glasgow’s School of Cardiovascular and Metabolic Health, said: “Our results from the landmark TARTAN-HF trial identified heart failure in a large proportion of people living with diabetes, emphasising the need for a heart failure screening strategy in this group of patients.
“We know that many of the symptoms and signs of heart failure are non-specific, and may go unrecognised as potentially being due to heart failure for a long time.
“The strategy used in our trial is simple and easy to implement in clinical practice, and will aid in the early identification of heart failure in people with diabetes, and facilitate the initiation of medications that we know improve outcomes in patients with heart failure.”
The study, which began more than three years ago, involved more than 700 people with diabetes from the two health board areas who had at least one other risk factor for heart failure.
They were randomly assigned either to receive heart failure screening or to continue with their usual care.
Researchers found screening uncovered a large number of previously unrecognised cases of heart failure. Around one in four, or 24.9 per cent, of those screened were found to have the condition within six months, compared with 1 per cent in the group continuing their usual care.
The study, involving patients with type 1 and type 2 diabetes, found almost all of the participants found to have heart failure had preserved ejection fraction, which can be difficult to detect without dedicated testing.
The findings of the TARTAN-HF trial were presented at the American College of Cardiology conference taking place from 28 to 30 March in New Orleans in the US.
Dr Edward Piper, medical director at AstraZeneca UK, said: “Delayed diagnosis and treatment of heart failure in people with type 2 diabetes contributes to poor long-term outcomes. TARTAN-HF demonstrates that targeted, risk-based screening can identify previously undiagnosed heart failure in approximately one in four high-risk patients with diabetes, enabling earlier intervention with guideline-directed therapy.”
Dr Christian Simon, head of global medical affairs at Roche Diagnostics, said: “We are proud to have supported the landmark TARTAN-HF trial. These findings demonstrate the transformative power of early, accessible diagnostics like the NT-proBNP blood test.
“By identifying unrecognised heart failure in people with diabetes, we enable clinicians to initiate appropriate treatments sooner, ultimately improving patient outcomes and lives.”
News
UK government announces £6.3m fund to boost men’s health

The UK has launched a £6.3m men’s health fund to back local projects aimed at helping men and boys live longer, healthier lives.
The Men’s Health Community Fund is a partnership between the Department of Health and Social Care, Movember and People’s Health Trust.
The government is contributing £3m, while the two charities are more than doubling that to take the total to £6.3m.
Grants will support community projects reaching underserved men and boys aged 16 and over, particularly in the most disadvantaged areas and at key points in their lives such as becoming a father, losing a job or retiring.
Projects could include support for new fathers, activities for men facing loneliness and social isolation, services to help young men engage with the health system, and support for men in work, out of work and moving into retirement.
The programme will bring together voluntary, community and social enterprise organisations to test new ways of reaching men who are least likely to use traditional health services.
An evaluation funded through the National Institute for Health and Care Research will assess what works and help inform future policy and delivery.
Health and social care secretary Wes Streeting said: “Too many men across the country are living shorter, less healthy lives, particularly those in our most disadvantaged communities.
“This new partnership will help men get the support they need in the places they feel most comfortable, their communities, among people they trust.
“By working with expert charities and local organisations, we can reach the men who are too often missed by traditional services and help them take better care of their mental and physical health.”
“It is a key step in delivering our first ever Men’s Health Strategy and driving forward our ambition to halve the gap in healthy life expectancy between the richest and poorest areas.”
The Men’s Health Strategy sets out plans to tackle the physical and mental health challenges men and boys face.
Men can be less likely to seek help and more likely to suffer in silence, while higher rates of smoking, drinking, gambling and drug use are damaging men’s health and affecting families, workplaces and communities.
The government is also investing £3.6m over the next three years in suicide prevention projects for middle-aged men in local communities across areas of England where men are most at risk, many of which are also among the most deprived. Suicide is one of the biggest killers of men under 50, and three-quarters of all suicides are men.
The projects will aim to break down barriers middle-aged men face in seeking support, including stigma around asking for help and a lack of awareness of what is available and how to access it.
They will be co-designed with experts and men with lived experience of mental health crises and suicidal thoughts.
News4 weeks agoAgetech world investment, research and technology round-up
News4 weeks agoAtrogi starts muscle-preserving drug trial
News4 weeks agoLandmark prostate cancer screening trial begins in UK
News4 weeks agoNHS to review cost effectiveness of new Alzheimer’s drugs
News3 weeks agoCentenarian study probes healthy ageing
News3 weeks agoActive sitting linked to lower dementia risk
News3 weeks agoEndogenex raises US$50m for diabetes procedure
News4 weeks agoWorking nights undermines type 2 diabetes management – study















